Essential fatty acid deficiency in critically III surgical patients

Mary C. McCarthy, G. Larry Cottam, William W. Turner

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Plasma fatty acid profiles of 33 critically ill surgical patients receiving fat-free parenteral nutrition were examined at weekly intervals up to 28 days. While plasma total fatty acid concentration remained relatively constant and within the normal range, marked compositional alterations were apparent. Levels of linoleate (18:2ω6), the major essential fatty acid in man, fell below normal values (754 ± 259 μg/ml) in 67 percent of patients within 1 week after cessation of oral intake. Decreases in other ω6 unsaturated fatty acids, derived from linoleate, were also apparent. In contrast, gradual increases were observed in levels of endogenously synthesized fatty acids, palmitate (16:0), palmitoleate (16:1) and oleate (18:1ω9). A fatty acid unique to essential fatty acid deficiency, 5,8,11 eicosatrienoate (20:3ω9), appeared in 25 percent of the patients during the first week and in all patients by the third week of study. Considering the rapid appearance and progression of these bio-chemical changes, early initiation of linoleate supplementation appears justified to forestall the development of related clinical sequelae.

Original languageEnglish (US)
Pages (from-to)747-751
Number of pages5
JournalThe American Journal of Surgery
Volume142
Issue number6
DOIs
StatePublished - 1981

Fingerprint

Essential Fatty Acids
Linoleic Acid
Fatty Acids
Reference Values
Palmitates
Parenteral Nutrition
Oleic Acid
Unsaturated Fatty Acids
Critical Illness
Fats

ASJC Scopus subject areas

  • Surgery

Cite this

Essential fatty acid deficiency in critically III surgical patients. / McCarthy, Mary C.; Cottam, G. Larry; Turner, William W.

In: The American Journal of Surgery, Vol. 142, No. 6, 1981, p. 747-751.

Research output: Contribution to journalArticle

McCarthy, Mary C. ; Cottam, G. Larry ; Turner, William W. / Essential fatty acid deficiency in critically III surgical patients. In: The American Journal of Surgery. 1981 ; Vol. 142, No. 6. pp. 747-751.
@article{1e98be2f54194d789ef97e49bb30b904,
title = "Essential fatty acid deficiency in critically III surgical patients",
abstract = "Plasma fatty acid profiles of 33 critically ill surgical patients receiving fat-free parenteral nutrition were examined at weekly intervals up to 28 days. While plasma total fatty acid concentration remained relatively constant and within the normal range, marked compositional alterations were apparent. Levels of linoleate (18:2ω6), the major essential fatty acid in man, fell below normal values (754 ± 259 μg/ml) in 67 percent of patients within 1 week after cessation of oral intake. Decreases in other ω6 unsaturated fatty acids, derived from linoleate, were also apparent. In contrast, gradual increases were observed in levels of endogenously synthesized fatty acids, palmitate (16:0), palmitoleate (16:1) and oleate (18:1ω9). A fatty acid unique to essential fatty acid deficiency, 5,8,11 eicosatrienoate (20:3ω9), appeared in 25 percent of the patients during the first week and in all patients by the third week of study. Considering the rapid appearance and progression of these bio-chemical changes, early initiation of linoleate supplementation appears justified to forestall the development of related clinical sequelae.",
author = "McCarthy, {Mary C.} and Cottam, {G. Larry} and Turner, {William W.}",
year = "1981",
doi = "10.1016/0002-9610(81)90326-3",
language = "English (US)",
volume = "142",
pages = "747--751",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Essential fatty acid deficiency in critically III surgical patients

AU - McCarthy, Mary C.

AU - Cottam, G. Larry

AU - Turner, William W.

PY - 1981

Y1 - 1981

N2 - Plasma fatty acid profiles of 33 critically ill surgical patients receiving fat-free parenteral nutrition were examined at weekly intervals up to 28 days. While plasma total fatty acid concentration remained relatively constant and within the normal range, marked compositional alterations were apparent. Levels of linoleate (18:2ω6), the major essential fatty acid in man, fell below normal values (754 ± 259 μg/ml) in 67 percent of patients within 1 week after cessation of oral intake. Decreases in other ω6 unsaturated fatty acids, derived from linoleate, were also apparent. In contrast, gradual increases were observed in levels of endogenously synthesized fatty acids, palmitate (16:0), palmitoleate (16:1) and oleate (18:1ω9). A fatty acid unique to essential fatty acid deficiency, 5,8,11 eicosatrienoate (20:3ω9), appeared in 25 percent of the patients during the first week and in all patients by the third week of study. Considering the rapid appearance and progression of these bio-chemical changes, early initiation of linoleate supplementation appears justified to forestall the development of related clinical sequelae.

AB - Plasma fatty acid profiles of 33 critically ill surgical patients receiving fat-free parenteral nutrition were examined at weekly intervals up to 28 days. While plasma total fatty acid concentration remained relatively constant and within the normal range, marked compositional alterations were apparent. Levels of linoleate (18:2ω6), the major essential fatty acid in man, fell below normal values (754 ± 259 μg/ml) in 67 percent of patients within 1 week after cessation of oral intake. Decreases in other ω6 unsaturated fatty acids, derived from linoleate, were also apparent. In contrast, gradual increases were observed in levels of endogenously synthesized fatty acids, palmitate (16:0), palmitoleate (16:1) and oleate (18:1ω9). A fatty acid unique to essential fatty acid deficiency, 5,8,11 eicosatrienoate (20:3ω9), appeared in 25 percent of the patients during the first week and in all patients by the third week of study. Considering the rapid appearance and progression of these bio-chemical changes, early initiation of linoleate supplementation appears justified to forestall the development of related clinical sequelae.

UR - http://www.scopus.com/inward/record.url?scp=0019749014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019749014&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(81)90326-3

DO - 10.1016/0002-9610(81)90326-3

M3 - Article

VL - 142

SP - 747

EP - 751

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -